Semax

Semax is a synthetic seven-amino-acid peptide designed from the ACTH 4–7 fragment and extended with a Pro-Gly-Pro sequence. It is studied in neurobiology and does not belong to the GLP-1 agonist family.

No. Semax is a modified peptide built from a fragment of that hormone. Its origin does not mean that all ACTH actions, including those on cortisol production, can automatically be attributed to it.

Neurotrophic factors contribute to nerve-cell function and responses. Experimental Semax studies examine pathways related to BDNF and NGF, among others. These molecular findings must be distinguished from clinical efficacy.

Research addresses neuronal responses, plasticity and certain models of injury or cellular stress. Interpretation depends on the protocol, species and measured outcomes.

Semax is derived from an ACTH fragment; Selank is derived from tuftsin. Their equal length does not make them identical. A study of one cannot serve as evidence for the other.

No. The product page may explain the topics studied, but it must not turn experimental observations into a guarantee of cognitive improvement. The catalogue product remains a reference intended for research.

Review the analytical documentation available for the batch and confirm that it matches the reference ordered. Identity, purity and quantity are different pieces of information. A purity percentage alone does not establish sterility or the absence of endotoxins.

Follow the conditions on the label and in the batch documentation, together with your laboratory’s validated procedures. Conditions for a lyophilized powder may differ from those for a solution. Without reference-specific data, do not infer stability from another product.

No. This reference is intended for laboratory research, not human consumption or personal medical use. Scientific explanations are not prescriptions, and the quantities shown per vial are not usage doses.